Soft Tissue Sarcoma: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for soft tissue sarcomas. To learn more about a study, choose from the list below.

Showing 8 trials
Titlesort icon Investigator
A Phase 1B/II Study of GDC-0449 Plus RO4929097 in Advanced/Metastatic Sarcomas
[Protocol 10-049] 		Schwartz, Gary, MD
A Phase I/II Study of CDX-1401 in Patients with Cancers Known to Express NY-ESO-1
[Protocol 09-165] 		Keohan, Mary, MD
A Phase IB/II Study Evaluating Doxorubicin with or without a IMC-3G3 to Treat Advanced Soft-Tissue Sarcoma
[Protocol 10-156] 		Tap, William, MD
A Phase Ib/II Study of Gemcitabine and Docetaxel Plus Pazopanib for the Neoadjuvant (Presurgical) Treatment of Soft-Tissue Sarcoma
[Protocol 11-104] 		Tap, William, MD
A Phase II Study of PD0332991 in Patients with Advanced or Metastatic Liposarcoma
[Protocol 10-094] 		Dickson, Mark, MD
A Phase III Study of Docetaxel and Gemcitabine With or Without Bevacizumab in Women with Recurrent or Advanced Leiomyosarcoma of the Uterus
[Protocol 10-048] 		Hensley, Martee, MD
A Phase III Study of Paclitaxel plus Carboplatin Versus Ifosfamide plus Paclitaxel in Chemotherapy-Naive Patients with Newly Diagnosed Persistent or Recurrent Carcinosarcoma of the Uterus
[Protocol 10-007] 		Hensley, Martee, MD
The Evaluation of Pazopanib for Treating Recurrent or Persistent Carcinosarcoma of the Uterus
[Protocol 11-064] 		Hensley, Martee, MD
Recommended Links

Clinical Trials

Clinical trials can offer you access to a new, experimental treatment before it is available to most patients. Joining a clinical trial is also a way to make a valuable contribution toward the fight against cancer.